Trials / Conditions / Solid Organ Transplant

Solid Organ Transplant

20 registered clinical trials studyying Solid Organ Transplant — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation. NCT06529536	Murdoch Childrens Research Institute	Phase 4
Completed	Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients NCT05663463	University of Minnesota	N/A
Recruiting	iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients NCT05968807	The Hospital for Sick Children	N/A
Unknown	REmote moBile Outpatient mOnitoring in Transplant 2.0 NCT04721288	University Health Network, Toronto	N/A
Recruiting	Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Rec NCT05550298	Arkansas Children's Hospital Research Institute	—
Completed	Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipi NCT05164016	St. Jude Children's Research Hospital	—
Completed	Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease NCT05121142	Children's Hospital Medical Center, Cincinnati	Phase 1
Completed	Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant NCT05124509	Pontificia Universidad Catolica de Chile	—
Completed	iPeer2Peer Pediatric Thoracic Transplantation NCT04253548	The Hospital for Sick Children	N/A
Completed	Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against CO NCT04844489	Assistance Publique - Hôpitaux de Paris	N/A
Active Not Recruiting	High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients NCT04613206	Vanderbilt University Medical Center	Phase 2
Active Not Recruiting	Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant NCT04331275	Children's Hospital Medical Center, Cincinnati	Phase 2
Terminated	A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Soli NCT03950414	University of Wisconsin, Madison	Phase 1
Withdrawn	Early Flu Shots in SOT NCT03327987	University Health Network, Toronto	—
Withdrawn	Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile In NCT02464306	University of Colorado, Denver	Phase 4
Completed	Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 NCT03360682	Fundacion Clinic per a la Recerca Biomédica	Phase 4
Completed	Discharge to Home and Chronic Illness Care Pilot NCT02165423	Medical College of Wisconsin	N/A
Completed	Bortezomib Plus Rituximab for EBV+ PTLD NCT01058239	Massachusetts General Hospital	Phase 2
Completed	Transition From Hospital to Home in Solid Organ Transplant (SOT) NCT00907023	Medical College of Wisconsin	—
Completed	Fusariosis in Solid-Organ Transplant Recipients NCT00518778	University of Pittsburgh	—